Sep 24 |
Top 4 Health Care Stocks That May Keep You Up At Night
|
Sep 24 |
Esker And Two High Growth Tech Stocks In France
|
Sep 19 |
Genfit GAAP EPS of €0.53, revenue of €61.2M
|
Sep 19 |
GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
|
Jul 26 |
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
|
Jun 17 |
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
|
May 29 |
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
|
May 29 |
Genfit: Under The Radar Biotech With Upcoming Catalysts
|
Apr 25 |
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
|
Apr 15 |
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
|